Clinical Trial Update: Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating genetic risk estimation for breast cancer prior to preventive medication uptake.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED